After a few years of growing pains, the burgeoning autism treatment industry is beginning to mature. But maturation comes with a price: rising expectations from payers and investors alike. With rates for applied behavior analysis (ABA) fluctuating across state Medicaid programs and more pressure to curb spending from commercial plans, there is a greater emphasis on providing quality outcomes. Still, providers need to standardize the most important outcomes to demonstrate; otherwise, payers will do it for them. And relationships with payers are a key driver in M&A activity. Investors want to fund organizations that have a healthy reimbursement strategy.
Read the full article: Autism Care Faces Market Reckoning as Payers, Investors Push for Proof of Outcomes //
Source: https://bhbusiness.com/2025/11/21/autism-care-faces-market-reckoning-as-payers-investors-push-for-proof-of-outcomes/